RAUL
ORTIZ DE LEJARAZU LEONARDO
Investigador en el periodo 1983-2019
Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública (19)
2020
-
Effect of antiviral treatment in older patients hospitalized with confirmed influenza
Antiviral Research, Vol. 178
2018
-
Erratum to “Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe – Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18” [Vaccine 35 (2017) 4828–4835] (S0264410X17309659) (10.1016/j.vaccine.2017.07.057))
Vaccine
-
Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016
Influenza and other Respiratory Viruses, Vol. 12, Núm. 1, pp. 161-170
-
Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: A multicentre case-control study
CMAJ, Vol. 190, Núm. 1, pp. E3-E12
2017
-
Costs associated with influenza-related hospitalization in the elderly
Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416
-
Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain
PLoS ONE, Vol. 12, Núm. 2
-
Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons
Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 450-455
-
Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18
Vaccine, Vol. 35, Núm. 37, pp. 4828-4835
-
The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: A multicentre case–control study, Spain, 2013/14 and 2014/15
Eurosurveillance, Vol. 22, Núm. 34
2016
-
Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study
Human Vaccines and Immunotherapeutics, Vol. 12, Núm. 7, pp. 1891-1899
-
High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307
2015
-
Influenza surveillance in Europe: Comparing intensity levels calculated using the moving epidemic method
Influenza and other Respiratory Viruses, Vol. 9, Núm. 5, pp. 234-246
-
No major host genetic risk factor contributed to A(H1N1)2009 influenza severity
PLoS ONE, Vol. 10, Núm. 9
2014
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
-
Predictive factors of severe multilobar pneumonia and shock in patients with influenza
Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307
2013
-
Risk factors and effectiveness of preventive measures against influenza in the community
Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183
2012
-
Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization
Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439